Microbial Immunology
Microbiology is that the study of a cellular and multi-celled microscopic organisms. Several microorganisms cause dangerous infectious diseases. Medicine is that the study of the system in an exceedingly diversity of organisms. The study of medicine semiconductor diode to the expansion of medical biology, that deals with identification, and mechanism of action of infectious agents. The disease-causing organisms area unit referred to as pathogens and their mode of assaultive the host and its effects on host is pathological process.
- Thymus and lymphocyte Immunobiology
- T-cell Immunology
- Systemic Lupus Erythematous
Related Conference of Microbial Immunology
April 22-23, 2025
8th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
Microbial Immunology Conference Speakers
Recommended Sessions
- Antibiotics, Antimicrobial & Chemotherapy
- Antimicrobial Pathogens : Alternative Approaches
- Antimicrobials
- Antimicrobiology in Epidemiology
- COVID 19 in Antimicrobial and Antibacterial Agents
- Global Spread of Viruses
- Immunity , Infection Diseases and Agents
- Microbial Immunology
- Microbial Physiology and Metabolism
- Microorganisms in Recent Drug Discovery
- Pharmaceutical microbiology
- Pharmalogical Consideration of Infectious Disease and Agents
- Vaccine and Vaccination
- Vaccines and Therapeutics
Related Journals
Are you interested in
- Advancements in Vaccine Adjuvants - Vaccines R&D 2025 (France)
- Advances in Vaccine Safety Monitoring - Vaccines R&D 2025 (France)
- AI & Big Data in Vaccine Research - VACCINE CONGRESS 2025 (UAE)
- Antimicrobial Resistance (AMR) - VACCINES WORLD 2025 (Italy)
- Antimicrobial Resistance (AMR) - VACCINE CONGRESS 2025 (UAE)
- Bioprocessing and Manufacturing - VACCINES WORLD 2025 (Italy)
- Biosecurity and Bioterrorism Preparedness - GLOBAL VACCINE 2025 (Indonesia)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2025 (France)
- Cancer Vaccines and Immunotherapy - GLOBAL VACCINE 2025 (Indonesia)
- Cancer Vaccines and Immunotherapy - VACCINES WORLD 2025 (Italy)
- Cancer Vaccines and Immunotherapy - VACCINE CONGRESS 2025 (UAE)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2025 (France)
- Clinical Trials - VACCINE CONGRESS 2025 (UAE)
- Clinical Trials - VACCINES WORLD 2025 (Italy)
- Clinical Trials and Regulatory Affairs - GLOBAL VACCINE 2025 (Indonesia)
- Clinical Trials and Vaccine Research - Vaccines R&D 2025 (France)
- Community Engagement and Public Health Campaigns - Vaccines R&D 2025 (France)
- Conjugate Vaccine - GLOBAL VACCINE 2025 (Indonesia)
- Conjugate Vaccine - VACCINES WORLD 2025 (Italy)
- Coronavirus (COVID-19) & Pandemic Vaccines - VACCINES WORLD 2025 (Italy)
- COVID-19 Vaccine - VACCINE CONGRESS 2025 (UAE)
- DNA Vaccines - Euro Vaccines 2025 (France)
- DNA-RNA Vaccines - VACCINES WORLD 2025 (Italy)
- Emerging and Re-Emerging Diseases - VACCINES WORLD 2025 (Italy)
- Emerging Infectious Disease Vaccines - VACCINE CONGRESS 2025 (UAE)
- Emerging Technologies in Diagnostics - GLOBAL VACCINE 2025 (Indonesia)
- Epidemiology and Public Health - GLOBAL VACCINE 2025 (Indonesia)
- Ethics and Public Policy in Vaccination - Vaccines R&D 2025 (France)
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines - VACCINES WORLD 2025 (Italy)
- Global Vaccine Distribution Challenges - Vaccines R&D 2025 (France)
- Global Vaccine Equity - VACCINE CONGRESS 2025 (UAE)
- Hepatitis Vaccines - Euro Vaccines 2025 (France)
- HIV Vaccines - VACCINES WORLD 2025 (Italy)
- HIV Vaccines - GLOBAL VACCINE 2025 (Indonesia)
- HIV Vaccines - VACCINE CONGRESS 2025 (UAE)
- HIV/AIDS Vaccines - Euro Vaccines 2025 (France)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2025 (France)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2025 (France)
- Immune Profiling - VACCINES WORLD 2025 (Italy)
- Immunization Programs and Strategies - GLOBAL VACCINE 2025 (Indonesia)
- Immunology Advances and Vaccine Efficacy - Vaccines R&D 2025 (France)
- Immunology/Animal Models - Euro Vaccines 2025 (France)
- Impact of Climate Change on Infectious Disease and Vaccination - Vaccines R&D 2025 (France)
- Infectious and Non-Infectious Diseases - VACCINE CONGRESS 2025 (UAE)
- Infectious and Non-Infectious Diseases - VACCINES WORLD 2025 (Italy)
- Influenza & Respiratory Virus Vaccines - VACCINE CONGRESS 2025 (UAE)
- Influenza and Respiratory Vaccines - VACCINES WORLD 2025 (Italy)
- Innovations in Vaccine Formulation and Delivery - Vaccines R&D 2025 (France)
- Innovative Vaccine Development - GLOBAL VACCINE 2025 (Indonesia)
- Innovative Vaccine Technologies - Vaccines R&D 2025 (France)
- Integration of Digital Health in Immunization - Vaccines R&D 2025 (France)
- mRNA Vaccine Innovations - VACCINE CONGRESS 2025 (UAE)
- Mucosal Vaccines - Euro Vaccines 2025 (France)
- Nanotechnology in vaccines - GLOBAL VACCINE 2025 (Indonesia)
- Next-Generation Vaccine Delivery Technologies - GLOBAL VACCINE 2025 (Indonesia)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2025 (France)
- Novel Adjuvants & Delivery Systems - VACCINE CONGRESS 2025 (UAE)
- One Health: Zoonotic Disease Vaccines - VACCINE CONGRESS 2025 (UAE)
- Pandemic Preparedness and Response - GLOBAL VACCINE 2025 (Indonesia)
- Pediatric Vaccines: Trends & Future - VACCINE CONGRESS 2025 (UAE)
- Personalized Immunization Strategies - Vaccines R&D 2025 (France)
- Personalized Vaccinology - VACCINE CONGRESS 2025 (UAE)
- Rapid Vaccine Development and Deployment - Vaccines R&D 2025 (France)
- Regulatory Pathways in Vaccines - VACCINE CONGRESS 2025 (UAE)
- Technological Innovations in Vaccinology - GLOBAL VACCINE 2025 (Indonesia)
- Thermo Stabilized Vaccines - VACCINES WORLD 2025 (Italy)
- Thermo-stabilized vaccines - GLOBAL VACCINE 2025 (Indonesia)
- Vaccination in Special Populations - Vaccines R&D 2025 (France)
- Vaccine Access and Equity - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Adjuvants - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Adjuvants - VACCINES WORLD 2025 (Italy)
- Vaccine Adjuvants - Euro Vaccines 2025 (France)
- Vaccine Hesitancy & Public Engagement - VACCINE CONGRESS 2025 (UAE)
- Vaccine Innovation for Emerging Diseases - Vaccines R&D 2025 (France)
- Vaccine Manufacturing Advances - VACCINE CONGRESS 2025 (UAE)
- Vaccine Production, Supply & Logistics - VACCINES WORLD 2025 (Italy)
- Vaccine Research & Development - VACCINE CONGRESS 2025 (UAE)
- Vaccine Research & Development - Euro Vaccines 2025 (France)
- Vaccine Research and Development - VACCINES WORLD 2025 (Italy)
- Vaccine Research and Development - GLOBAL VACCINE 2025 (Indonesia)
- Vaccine Safety & Immunogenicity - VACCINE CONGRESS 2025 (UAE)
- Vaccine Safety, Efficacy & Regulatory Affairs - VACCINES WORLD 2025 (Italy)
- Vaccine-Preventable Diseases - VACCINE CONGRESS 2025 (UAE)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2025 (France)
- Vaccines and Emerging Diseases - GLOBAL VACCINE 2025 (Indonesia)
- Vaccines Business Development - Euro Vaccines 2025 (France)
- Vaccines Epidemiology & Immunology - VACCINE CONGRESS 2025 (UAE)
- Vaccines for Older Adults - Euro Vaccines 2025 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2025 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2025 (France)
- Vaccines Safety & Efficacy - Euro Vaccines 2025 (France)
- Veterinary Vaccine - VACCINE CONGRESS 2025 (UAE)
- Veterinary Vaccine - VACCINES WORLD 2025 (Italy)
- Veterinary Vaccines - Euro Vaccines 2025 (France)
- Veterinary vaccines - GLOBAL VACCINE 2025 (Indonesia)